Products

MelaSense is an innovative biosensor designed to detect Notch1 protein in nodular melanoma patients using saliva samples for non-invasive testing. It leverages aptamer-based technology to provide highly accurate results, differentiating between individuals with and without the protein. The device is cost-effective, portable, and tailored for remote areas and underdeveloped countries with limited healthcare infrastructure. With over 95% sensitivity and specificity, MelaSense offers a reliable solution for monitoring disease progression and treatment response. Its accessibility and affordability make it a groundbreaking tool for global cancer care.